annual CFO:
$239.81M+$96.21M(+67.00%)Summary
- As of today (June 28, 2025), CPRX annual cash flow from operations is $239.81 million, with the most recent change of +$96.21 million (+67.00%) on December 31, 2024.
- During the last 3 years, CPRX annual CFO has risen by +$179.44 million (+297.22%).
- CPRX annual CFO is now at all-time high.
Performance
CPRX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$60.04M-$10.83M(-15.29%)Summary
- As of today (June 28, 2025), CPRX quarterly cash flow from operations is $60.04 million, with the most recent change of -$10.83 million (-15.29%) on March 31, 2025.
- Over the past year, CPRX quarterly CFO has increased by +$28.12 million (+88.08%).
- CPRX quarterly CFO is now -17.60% below its all-time high of $72.87 million, reached on September 30, 2024.
Performance
CPRX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$267.93M+$28.12M(+11.73%)Summary
- As of today (June 28, 2025), CPRX TTM cash flow from operations is $267.93 million, with the most recent change of +$28.12 million (+11.73%) on March 31, 2025.
- Over the past year, CPRX TTM CFO has increased by +$104.47 million (+63.91%).
- CPRX TTM CFO is now at all-time high.
Performance
CPRX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CPRX Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +67.0% | +88.1% | +63.9% |
| 3 y3 years | +297.2% | +608.2% | +312.0% |
| 5 y5 years | +592.9% | +732.4% | +437.6% |
CPRX Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +297.2% | -17.6% | +608.2% | at high | +312.0% |
| 5 y | 5-year | at high | +592.9% | -17.6% | +1474.3% | at high | +543.5% |
| alltime | all time | at high | +1017.1% | -17.6% | +818.9% | at high | +1054.1% |
CPRX Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $60.04M(-15.3%) | $267.93M(+11.7%) |
| Dec 2024 | $239.81M(+67.0%) | $70.88M(-2.7%) | $239.81M(+6.8%) |
| Sep 2024 | - | $72.87M(+13.6%) | $224.58M(+14.1%) |
| Jun 2024 | - | $64.14M(+100.9%) | $196.84M(+20.4%) |
| Mar 2024 | - | $31.93M(-42.6%) | $163.46M(+13.8%) |
| Dec 2023 | $143.60M(+23.7%) | $55.65M(+23.3%) | $143.60M(+12.2%) |
| Sep 2023 | - | $45.13M(+46.7%) | $128.03M(+3.1%) |
| Jun 2023 | - | $30.75M(+154.8%) | $124.20M(+3.8%) |
| Mar 2023 | - | $12.07M(-69.9%) | $119.64M(+3.1%) |
| Dec 2022 | $116.05M(+92.2%) | $40.08M(-3.0%) | $116.05M(+22.0%) |
| Sep 2022 | - | $41.30M(+57.7%) | $95.15M(+25.9%) |
| Jun 2022 | - | $26.19M(+208.9%) | $75.55M(+16.2%) |
| Mar 2022 | - | $8.48M(-55.8%) | $65.04M(+7.7%) |
| Dec 2021 | $60.37M(+34.1%) | $19.18M(-11.7%) | $60.37M(+11.2%) |
| Sep 2021 | - | $21.71M(+38.5%) | $54.30M(+23.3%) |
| Jun 2021 | - | $15.68M(+311.0%) | $44.05M(+5.8%) |
| Mar 2021 | - | $3.81M(-70.9%) | $41.63M(-7.5%) |
| Dec 2020 | $45.03M(+30.1%) | $13.11M(+14.4%) | $45.03M(+1.8%) |
| Sep 2020 | - | $11.45M(-13.7%) | $44.22M(-9.8%) |
| Jun 2020 | - | $13.27M(+83.9%) | $49.03M(-1.6%) |
| Mar 2020 | - | $7.21M(-41.3%) | $49.84M(+44.0%) |
| Dec 2019 | $34.61M(-232.4%) | $12.29M(-24.4%) | $34.61M(+147.8%) |
| Sep 2019 | - | $16.26M(+15.6%) | $13.97M(-251.1%) |
| Jun 2019 | - | $14.07M(-275.6%) | -$9.25M(-67.1%) |
| Mar 2019 | - | -$8.02M(-4.0%) | -$28.08M(+7.4%) |
| Dec 2018 | -$26.15M(+90.3%) | -$8.35M(+20.1%) | -$26.15M(+19.8%) |
| Sep 2018 | - | -$6.95M(+46.0%) | -$21.83M(+24.7%) |
| Jun 2018 | - | -$4.76M(-21.7%) | -$17.51M(+9.8%) |
| Mar 2018 | - | -$6.08M(+50.9%) | -$15.95M(+16.0%) |
| Dec 2017 | -$13.74M(-23.5%) | -$4.03M(+53.1%) | -$13.74M(-2.7%) |
| Sep 2017 | - | -$2.63M(-17.8%) | -$14.12M(-4.4%) |
| Jun 2017 | - | -$3.20M(-17.5%) | -$14.77M(-7.2%) |
| Mar 2017 | - | -$3.88M(-12.1%) | -$15.91M(-11.4%) |
| Dec 2016 | -$17.96M(-0.3%) | -$4.41M(+34.6%) | -$17.96M(-1.2%) |
| Sep 2016 | - | -$3.28M(-24.5%) | -$18.18M(-10.2%) |
| Jun 2016 | - | -$4.34M(-26.8%) | -$20.25M(+0.5%) |
| Mar 2016 | - | -$5.93M(+28.0%) | -$20.15M(+11.9%) |
| Dec 2015 | -$18.02M | -$4.63M(-13.3%) | -$18.02M(+3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | -$5.34M(+25.8%) | -$17.36M(+11.5%) |
| Jun 2015 | - | -$4.25M(+11.9%) | -$15.57M(+8.8%) |
| Mar 2015 | - | -$3.79M(-4.6%) | -$14.31M(+10.6%) |
| Dec 2014 | -$12.94M(+31.0%) | -$3.98M(+12.0%) | -$12.94M(-1.1%) |
| Sep 2014 | - | -$3.55M(+19.1%) | -$13.09M(+16.7%) |
| Jun 2014 | - | -$2.98M(+23.0%) | -$11.22M(+11.7%) |
| Mar 2014 | - | -$2.42M(-41.3%) | -$10.05M(+1.8%) |
| Dec 2013 | -$9.88M(+92.1%) | -$4.13M(+145.3%) | -$9.88M(+34.6%) |
| Sep 2013 | - | -$1.68M(-7.1%) | -$7.34M(+8.6%) |
| Jun 2013 | - | -$1.81M(-19.4%) | -$6.76M(+11.0%) |
| Mar 2013 | - | -$2.25M(+41.1%) | -$6.09M(+18.4%) |
| Dec 2012 | -$5.14M(+3.1%) | -$1.59M(+44.8%) | -$5.14M(+3.1%) |
| Sep 2012 | - | -$1.10M(-3.8%) | -$4.98M(-3.0%) |
| Jun 2012 | - | -$1.14M(-12.1%) | -$5.14M(-5.8%) |
| Mar 2012 | - | -$1.30M(-9.5%) | -$5.46M(+9.4%) |
| Dec 2011 | -$4.99M(+32.7%) | -$1.44M(+14.8%) | -$4.99M(+15.5%) |
| Sep 2011 | - | -$1.25M(-14.4%) | -$4.32M(+11.2%) |
| Jun 2011 | - | -$1.46M(+76.0%) | -$3.88M(+8.8%) |
| Mar 2011 | - | -$831.10K(+8.0%) | -$3.57M(-5.1%) |
| Dec 2010 | -$3.76M(-51.1%) | -$769.20K(-5.9%) | -$3.76M(-1.6%) |
| Sep 2010 | - | -$817.30K(-28.9%) | -$3.82M(-12.3%) |
| Jun 2010 | - | -$1.15M(+12.5%) | -$4.35M(-25.8%) |
| Mar 2010 | - | -$1.02M(+23.2%) | -$5.87M(-23.6%) |
| Dec 2009 | -$7.68M(-7.0%) | -$828.90K(-38.7%) | -$7.68M(-21.2%) |
| Sep 2009 | - | -$1.35M(-49.2%) | -$9.75M(-10.7%) |
| Jun 2009 | - | -$2.66M(-6.1%) | -$10.92M(+10.6%) |
| Mar 2009 | - | -$2.84M(-2.2%) | -$9.87M(+19.5%) |
| Dec 2008 | -$8.26M(+86.7%) | -$2.90M(+15.1%) | -$8.26M(+31.3%) |
| Sep 2008 | - | -$2.52M(+56.0%) | -$6.29M(+41.0%) |
| Jun 2008 | - | -$1.62M(+32.0%) | -$4.46M(+4.2%) |
| Mar 2008 | - | -$1.22M(+31.3%) | -$4.28M(-3.2%) |
| Dec 2007 | -$4.42M(+275.5%) | -$932.30K(+34.7%) | -$4.42M(+26.7%) |
| Sep 2007 | - | -$692.10K(-51.8%) | -$3.49M(+24.7%) |
| Jun 2007 | - | -$1.43M(+5.1%) | -$2.80M(+105.1%) |
| Mar 2007 | - | -$1.37M | -$1.37M |
| Dec 2006 | -$1.18M(+158.8%) | - | - |
| Dec 2005 | -$455.40K(+97.6%) | - | - |
| Dec 2004 | -$230.50K | - | - |
FAQ
- What is Catalyst Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual CFO year-on-year change?
- What is Catalyst Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly CFO year-on-year change?
- What is Catalyst Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals TTM CFO year-on-year change?
What is Catalyst Pharmaceuticals annual cash flow from operations?
The current annual CFO of CPRX is $239.81M
What is the all time high annual CFO for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual cash flow from operations is $239.81M
What is Catalyst Pharmaceuticals annual CFO year-on-year change?
Over the past year, CPRX annual cash flow from operations has changed by +$96.21M (+67.00%)
What is Catalyst Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of CPRX is $60.04M
What is the all time high quarterly CFO for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly cash flow from operations is $72.87M
What is Catalyst Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, CPRX quarterly cash flow from operations has changed by +$28.12M (+88.08%)
What is Catalyst Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of CPRX is $267.93M
What is the all time high TTM CFO for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high TTM cash flow from operations is $267.93M
What is Catalyst Pharmaceuticals TTM CFO year-on-year change?
Over the past year, CPRX TTM cash flow from operations has changed by +$104.47M (+63.91%)